Literature DB >> 31807922

Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.

Sarah Péricart1,2, Charlotte Waysse3, Aurore Siegfried4,5, Stephanie Struski6, Eric Delabesse7, Camille Laurent4,5,8, Solène Evrard4,5,8.   

Abstract

Histiocytic sarcoma (HS) is a rare aggressive hematologic neoplasm that can be associated with low-grade B cell lymphoma. The development of both neoplasms is currently being considered a transdifferentiation mechanism but remains elusive. We report the case of a 65-year-old patient with synchronous development of peritoneal/abdominal HS and grade 1-2 follicular lymphoma (FL). Cytogenetic analysis and targeted next-generation sequencing of both FL and HS tumors identified common genomic alterations such as IGH-BCL2 rearrangement, CREBBP and KMT2D, and aberrations of chromosomes 9q and 19q. However, only the HS tumor had a KRAS mutation while the lymph node involved by FL harbored a TNFAIP3 mutation and both tumors also showed distinct chromosomal alterations. This report strengthens the hypothesis of a common lymphoid progenitor which accumulates genetic alterations leading to two different hematologic malignant diseases with significantly distinct prognoses.

Entities:  

Keywords:  Follicular lymphoma; Histiocytic sarcoma; Targeted next-generation DNA sequencing; Transdifferentiation

Mesh:

Substances:

Year:  2019        PMID: 31807922     DOI: 10.1007/s00428-019-02691-w

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolution.

Authors:  Endi Wang; Charles Blake Hutchinson; Qin Huang; Siby Sebastian; Catherine Rehder; Angela Kanaly; Joseph Moore; Michael Datto
Journal:  Leuk Lymphoma       Date:  2010-05

2.  Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor.

Authors:  P Brunner; A Rufle; S Dirnhofer; A Lohri; N Willi; G Cathomas; A Tzankov; D Juskevicius
Journal:  Leukemia       Date:  2014-05-21       Impact factor: 11.528

Review 3.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

4.  Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation.

Authors:  Assia Bassarova; Gunhild Trøen; Alexander Fosså; Ida Munster Ikonomou; Klaus Beiske; Jahn M Nesland; Jan Delabie
Journal:  J Hematop       Date:  2009-05-09       Impact factor: 0.196

5.  Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.

Authors:  Sebastian Fernandez-Pol; Charles D Bangs; Athena Cherry; Daniel A Arber; Dita Gratzinger
Journal:  Hum Pathol       Date:  2016-04-28       Impact factor: 3.466

Review 6.  Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature.

Authors:  Da Zhang; Joseph McGuirk; Siddhartha Ganguly; Diane L Persons
Journal:  Int J Hematol       Date:  2009-04-03       Impact factor: 2.490

7.  Somatic mutations in histiocytic sarcoma identified by next generation sequencing.

Authors:  Qingqing Liu; Keith Tomaszewicz; Lloyd Hutchinson; Jason L Hornick; Bruce Woda; Hongbo Yu
Journal:  Virchows Arch       Date:  2016-06-03       Impact factor: 4.064

Review 8.  Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies.

Authors:  Maggie M Stoecker; Endi Wang
Journal:  Arch Pathol Lab Med       Date:  2013-06       Impact factor: 5.534

9.  Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation.

Authors:  Dava S West; Ahmet Dogan; Patrick S Quint; Melissa L Tricker-Klar; Julie C Porcher; Rhett P Ketterling; Mark E Law; Ellen D McPhail; David S Viswanatha; Paul J Kurtin; Linda N Dao; Ryan D Ritzer; Grzegorz S Nowakowski; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2013-07       Impact factor: 6.394

10.  Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:  Ahmet Zehir; Ryma Benayed; Ronak H Shah; Aijazuddin Syed; Sumit Middha; Hyunjae R Kim; Preethi Srinivasan; Jianjiong Gao; Debyani Chakravarty; Sean M Devlin; Matthew D Hellmann; David A Barron; Alison M Schram; Meera Hameed; Snjezana Dogan; Dara S Ross; Jaclyn F Hechtman; Deborah F DeLair; JinJuan Yao; Diana L Mandelker; Donavan T Cheng; Raghu Chandramohan; Abhinita S Mohanty; Ryan N Ptashkin; Gowtham Jayakumaran; Meera Prasad; Mustafa H Syed; Anoop Balakrishnan Rema; Zhen Y Liu; Khedoudja Nafa; Laetitia Borsu; Justyna Sadowska; Jacklyn Casanova; Ruben Bacares; Iwona J Kiecka; Anna Razumova; Julie B Son; Lisa Stewart; Tessara Baldi; Kerry A Mullaney; Hikmat Al-Ahmadie; Efsevia Vakiani; Adam A Abeshouse; Alexander V Penson; Philip Jonsson; Niedzica Camacho; Matthew T Chang; Helen H Won; Benjamin E Gross; Ritika Kundra; Zachary J Heins; Hsiao-Wei Chen; Sarah Phillips; Hongxin Zhang; Jiaojiao Wang; Angelica Ochoa; Jonathan Wills; Michael Eubank; Stacy B Thomas; Stuart M Gardos; Dalicia N Reales; Jesse Galle; Robert Durany; Roy Cambria; Wassim Abida; Andrea Cercek; Darren R Feldman; Mrinal M Gounder; A Ari Hakimi; James J Harding; Gopa Iyer; Yelena Y Janjigian; Emmet J Jordan; Ciara M Kelly; Maeve A Lowery; Luc G T Morris; Antonio M Omuro; Nitya Raj; Pedram Razavi; Alexander N Shoushtari; Neerav Shukla; Tara E Soumerai; Anna M Varghese; Rona Yaeger; Jonathan Coleman; Bernard Bochner; Gregory J Riely; Leonard B Saltz; Howard I Scher; Paul J Sabbatini; Mark E Robson; David S Klimstra; Barry S Taylor; Jose Baselga; Nikolaus Schultz; David M Hyman; Maria E Arcila; David B Solit; Marc Ladanyi; Michael F Berger
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

View more
  8 in total

1.  PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis.

Authors:  Leonie I Kroeze; B Scheijen; K M Hebeda; J Rijntjes; J A C W Luijks; D Evers; W Hobo; P J T A Groenen; M van den Brand
Journal:  Virchows Arch       Date:  2022-10-14       Impact factor: 4.535

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

3.  ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.

Authors:  Charlotte Syrykh; Loïc Ysebaert; Sarah Péricart; Solène M Evrard; Fabienne Meggetto; Salim Kanoun; Pierre Brousset; Camille Laurent
Journal:  Virchows Arch       Date:  2020-10-03       Impact factor: 4.064

4.  Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Authors:  Hui Liu; Qi Shen; Chung-Che Chang; Shimin Hu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 5.  KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Tamara Bittolo; Erika Tissino; Valter Gattei; Antonella Zucchetto
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

6.  Histiocytic Sarcoma Involving Cervical Vertebra: A Case Report and Review of the Literature.

Authors:  Eshagh Bahrami; Masoumeh Najafi; Amin Jahanbakhshi; Jaber Hatam; Saadat Molanaei; Patrizia Ciammella; Salvatore Cozzi
Journal:  Brain Sci       Date:  2022-07-21

7.  Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.

Authors:  Paul G Kemps; Konnie M Hebeda; Steven T Pals; Robert M Verdijk; King H Lam; Annette H Bruggink; Heleen S de Lil; Bart Ruiterkamp; Koen de Heer; Jan Am van Laar; Peter Jm Valk; Pim Mutsaers; Mark-David Levin; Pancras Cw Hogendoorn; Astrid Gs van Halteren
Journal:  J Pathol Clin Res       Date:  2020-08-27

Review 8.  Histiocytic and dendritic cell neoplasms of the mediastinum.

Authors:  Ezra Baraban; Kumarasen Cooper
Journal:  Mediastinum       Date:  2020-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.